Key result
Men in the highest quartile of baseline IL-6 concentration had a 2.3 times higher risk of future myocardial infarction compared to those in the lowest quartile.
Why the study?
Epidemiological data evaluating the role of interleukin-6 in atherogenesis and future myocardial infarction risk are sparse.
Does elevated baseline IL-6 increase the risk of future myocardial infarction in apparently healthy men?
Cohort (n=14,916)
null
null
No
Does elevated baseline IL-6 increase the risk of future myocardial infarction in apparently healthy men?
Elevated baseline levels of IL-6 in apparently healthy men are associated with a significantly increased risk of future myocardial infarction, supporting the role of inflammation in early atherogenesis.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“In practice, hs-CRP has been used to characterize residual inflammatory risk with levels ≥2 mg/L as an entry criterion for multiple trials. However, IL-6 is more specific and predictive, although it lacks a clinically validated cutpoint.”
IL-6 elevation may flag higher MI risk in healthy men; supports inflammation in early atherogenesis but leaves clinical utility open.
Background —Interleukin-6 (IL-6) plays a central role in inflammation and tissue injury. However, epidemiological data evaluating the role of IL-6 in atherogenesis are sparse. Methods and Results —In a prospective study involving 14 916 apparently healthy men, we measured baseline plasma concentration of IL-6 in 202 participants who subsequently developed myocardial infarction (MI) and in 202 study participants matched for age and smoking status who did not report vascular disease during a 6-year follow-up. Median concentrations of IL-6 at baseline were higher among men who subsequently had an MI than among those who did not (1.81 versus 1.46 pg/mL; P =0.002). The risk of future MI increased with increasing quartiles of baseline IL-6 concentration ( P for trend <0.001) such that men in the highest quartile at entry had a relative risk 2.3 times higher than those in the lowest quartile (95% CI 1.3 to 4.3, P =0.005); for each quartile increase in IL-6, there was a 38% increase in risk ( P =0.001).This relationship remained significant after adjustment for other cardiovascular risk factors, was stable over long periods of follow-up, and was present in all low-risk subgroups, including nonsmokers. Although the strongest correlate of IL-6 in these data was C-reactive protein ( r =0.43, P <0.001), the relationship of IL-6 with subsequent risk remained after control for this factor ( P <0.001). Conclusions —In apparently healthy men, elevated levels of IL-6 are associated with increased risk of future MI. These data thus support a role for cytokine-mediated inflammation in the early stages of atherogenesis.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Ridker et al. (2000) conducted a cohort in Myocardial Infarction (n=14,916). Plasma IL-6 concentration vs. null was evaluated on Risk of future myocardial infarction (RR 2.3, 95% CI 1.3 to 4.3, p=0.005). Men in the highest quartile of baseline IL-6 concentration had a 2.3 times higher risk of future myocardial infarction compared to those in the lowest quartile.
Synapse has enriched 10 related papers. Consider them for comparative context: